Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cells in Refractory Systemic Lupus Erythematosus

NCT06222853 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Systemic Lupus Erythematosus
CAR-T Cell Therapy

Interventions

BIOLOGICAL: anti-CD19-CAR-T cells

Sponsor

The Children's Hospital of Zhejiang University School of Medicine

Collaborators

[object Object]